Factor VII
-
Subject Areas on Research
- A radioreceptor assay for quantitating plasma factor VIII/von Willebrand's protein.
- Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
- Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
- Challenges for providing effective hemostasis in surgery and trauma.
- Cloning and characterization of the 5' end (exon 1) of the gene encoding human factor X.
- Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies.
- Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers.
- Fatal Thrombosis After Factor VII Administration During Extracorporeal Membrane Oxygenation.
- Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.
- Hemostatic properties of the FVIIa analog NN1731.
- Laboratory monitoring of high-dose factor VIIa therapy.
- Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia.
- Massive transfusion coagulopathy.
- Monitoring direct thrombin inhibitors: time for standardization.
- NovoSeven for non-hemophilia hemostasis.
- Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy.
- Population genetic and phylogenetic evidence for positive selection on regulatory mutations at the factor VII locus in humans.
- Procoagulant and platelet aggregating properties of antilymphocyte sera.
- Recombinant activated factor VII and the anaesthetist.
- Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
- Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
- Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein.
- Safety profile of recombinant factor VIIa.
- Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding.
- The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
- The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
- The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.
- Tissue factor around dermal vessels has bound factor VII in the absence of injury.
- Variations of cardiovascular disease associated genes exhibit sex-dependent influence on human longevity.
-
Keywords of People
- Hoffman, Maureane, Professor of Pathology, Immunology
- Levy, Jerrold Henry, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
- Wray, Gregory Allan, Professor of Biology, Evolutionary Anthropology